172 related articles for article (PubMed ID: 19797610)
1. Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.
Srivastava A; Lian LY; Maggs JL; Chaponda M; Pirmohamed M; Williams DP; Park BK
Drug Metab Dispos; 2010 Jan; 38(1):122-32. PubMed ID: 19797610
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study.
Pinheiro PF; Pereira SA; Harjivan SG; Martins IL; Marinho AT; Cipriano M; Jacob CC; Oliveira NG; Castro MF; Marques MM; Antunes AMM; Miranda JP
Arch Toxicol; 2017 Mar; 91(3):1199-1211. PubMed ID: 27417440
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Chen Y; Fitch WL
Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.
Chen J; Mannargudi BM; Xu L; Uetrecht J
Chem Res Toxicol; 2008 Sep; 21(9):1862-70. PubMed ID: 18729332
[TBL] [Abstract][Full Text] [Related]
5. Detection of drug bioactivation in vivo: mechanism of nevirapine-albumin conjugate formation in patients.
Meng X; Howarth A; Earnshaw CJ; Jenkins RE; French NS; Back DJ; Naisbitt DJ; Park BK
Chem Res Toxicol; 2013 Apr; 26(4):575-83. PubMed ID: 23448204
[TBL] [Abstract][Full Text] [Related]
6. Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation.
Dekker SJ; Zhang Y; Vos JC; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2016 Dec; 29(12):2136-2144. PubMed ID: 27989146
[TBL] [Abstract][Full Text] [Related]
7. Amino acid adduct formation by the nevirapine metabolite, 12-hydroxynevirapine--a possible factor in nevirapine toxicity.
Antunes AM; Godinho AL; Martins IL; Justino GC; Beland FA; Marques MM
Chem Res Toxicol; 2010 May; 23(5):888-99. PubMed ID: 20392079
[TBL] [Abstract][Full Text] [Related]
8. Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury.
Sharma AM; Li Y; Novalen M; Hayes MA; Uetrecht J
Chem Res Toxicol; 2012 Aug; 25(8):1708-19. PubMed ID: 22793666
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine.
Tateishi Y; Ohe T; Yasuda D; Takahashi K; Nakamura S; Kazuki Y; Mashino T
Drug Metab Pharmacokinet; 2020 Apr; 35(2):238-243. PubMed ID: 32184040
[TBL] [Abstract][Full Text] [Related]
10. Bioactivation of lamotrigine in vivo in rat and in vitro in human liver microsomes, hepatocytes, and epidermal keratinocytes: characterization of thioether conjugates by liquid chromatography/mass spectrometry and high field nuclear magnetic resonance spectroscopy.
Chen H; Grover S; Yu L; Walker G; Mutlib A
Chem Res Toxicol; 2010 Jan; 23(1):159-70. PubMed ID: 19961160
[TBL] [Abstract][Full Text] [Related]
11. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in hepatic and intestinal contributions to nevirapine biotransformation in rats.
Pinheiro PF; Marinho AT; Antunes AM; Marques MM; Pereira SA; Miranda JP
Chem Biol Interact; 2015 May; 233():115-21. PubMed ID: 25818046
[TBL] [Abstract][Full Text] [Related]
13. Singularities of nevirapine metabolism: from sex-dependent differences to idiosyncratic toxicity.
Marinho AT; Miranda JP; Caixas U; Charneira C; Gonçalves-Dias C; Marques MM; Monteiro EC; Antunes AMM; Pereira SA
Drug Metab Rev; 2019 Feb; 51(1):76-90. PubMed ID: 30712401
[TBL] [Abstract][Full Text] [Related]
14. Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation.
Zhuo X; Hartz RA; Bronson JJ; Wong H; Ahuja VT; Vrudhula VM; Leet JE; Huang S; Macor JE; Shu YZ
Drug Metab Dispos; 2010 Jan; 38(1):5-15. PubMed ID: 19833844
[TBL] [Abstract][Full Text] [Related]
15. Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore.
Graham EE; Walsh RJ; Hirst CM; Maggs JL; Martin S; Wild MJ; Wilson ID; Harding JR; Kenna JG; Peter RM; Williams DP; Park BK
J Pharmacol Exp Ther; 2008 Aug; 326(2):657-71. PubMed ID: 18451316
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
17. Identification of danger signals in nevirapine-induced skin rash.
Zhang X; Sharma AM; Uetrecht J
Chem Res Toxicol; 2013 Sep; 26(9):1378-83. PubMed ID: 23947594
[TBL] [Abstract][Full Text] [Related]
18. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
[TBL] [Abstract][Full Text] [Related]
19. 12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash.
Sharma AM; Novalen M; Tanino T; Uetrecht JP
Chem Res Toxicol; 2013 May; 26(5):817-27. PubMed ID: 23590230
[TBL] [Abstract][Full Text] [Related]
20. Nevirapine bioactivation and covalent binding in the skin.
Sharma AM; Klarskov K; Uetrecht J
Chem Res Toxicol; 2013 Mar; 26(3):410-21. PubMed ID: 23387501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
